Suppr超能文献

扶正祛邪方联合化疗治疗进展期胃癌:158例患者随访研究及动物实验研究

[Treatment of operated late gastric carcinoma with prescription of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy: follow-up study of 158 patients and experimental study in animals].

作者信息

Wang G T

机构信息

Ruijin Hospital, Shanghai Second Medical University.

出版信息

Zhong Xi Yi Jie He Za Zhi. 1990 Dec;10(12):712-6, 707.

PMID:2292115
Abstract

158 cases of late gastric carcinoma (11 males and 47 females, age 30-70 years) were treated postoperatively with TCM prescriptions of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy. The main ingredients were Radix Codonopsis Pilosulae, Radix Astragali seu Hedysari, Rhizoma Atractylodes, Herba Solani Hyrati, Herba Oldenlandiae and Herba Salviae. The prescription was individualized by adding or subtracting some herbs according to TCM syndrome diagnosis at the time of patient's visit. The decoction was given daily for a long time, three to four years or even longer. It was given alone or together with regimes of chemotherapy at random. The average survival rates at 3 and 5 years were 41.07% and 30.36% respectively. Seven patients have lived for more than 11 years. 10 years survival rate was 12.5%. The combination of Chinese medicine with chemotherapy was better than chemotherapy regime alone (single 5-Fu or CCNU+5-Fu, MMF). Immunological studies of the survivors revealed an enhancement of both humoral and cellular immunity especially the function of peripheral NK cells. The decoction had been given to mice bearing Ehrlich ascites tumor. The amount of ascitic fluid was reduced and its cancer cell count decreased besides a significant increase in over-all survival rate of the animals. It suggested that the above prescription might have an inhibitory or even killing effect on tumor cells. T cell immunity of the treated mice was also improved as seen among patients.

摘要

158例晚期胃癌患者(男111例,女47例,年龄30 - 70岁)术后采用扶正祛邪的中药方剂联合化疗进行治疗。主要成分有党参、黄芪、白术、白毛藤、白花蛇舌草、丹参。根据患者就诊时的中医证候诊断,加减某些药物使方剂个体化。汤剂长期每日服用,三至四年甚至更长时间。单独服用或与化疗方案随机联合使用。3年和5年的平均生存率分别为41.07%和30.36%。7例患者存活超过11年。10年生存率为12.5%。中药与化疗联合使用优于单纯化疗方案(单用5 - 氟尿嘧啶或环己亚硝脲 + 5 - 氟尿嘧啶、丝裂霉素)。对幸存者的免疫学研究显示,体液免疫和细胞免疫均增强,尤其是外周NK细胞的功能。该汤剂已给予荷艾氏腹水瘤小鼠。腹水减少,癌细胞计数下降,同时动物的总体生存率显著提高。这表明上述方剂可能对肿瘤细胞有抑制甚至杀伤作用。如在患者中所见,经治疗的小鼠的T细胞免疫也得到改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验